Antidepressants
effectiveness
overview
The
effectiveness studies of
serotonin, dopamine, and norepinephrine reuptake inhibitor
depression drugs can be broken down into one of four
categories:
In reviewing the studies below, it is fair to say that the expectations
of a drug side effect occurring when using a serotonin, dopamine, and
norepinephrine reuptake inhibitor drug are greater than getting relief of
depression symptoms that is greater than placebo.
Of 5,972 people suffering with
depression that participated in the serotonin, dopamine, and
norepinephrine reuptake inhibitor depression studies on this web page,
423 people suffering with depression achieved results better than
placebo. So what does this mean? First it means that for the 5,549
people suffering with depression that were started on serotonin,
dopamine, or norepinephrine reuptake inhibitor depression drugs, their
depression outcomes were no better than placebo. This means that 5,549
people with depression were exposed to the side effects and the cost of
these drugs with no hope of getting results in treatment of depression
that were better than placebo since only 423 people suffering with
depression received results that
were better than placebo. When you analyze these studies, the bottom line is that only 7.08% of
people suffering with depression treated with the
serotonin, dopamine, or norepinephrine reuptake inhibitor depression drugs
got relief of depression symptoms that were better than placebo. I.e. they treated
everyone so that 7.08% could get depression results better than a sugar pill, and
92.92% got the same results in treatment of depression as if they had taken a sugar pill.
In the "warnings, precautions, and adverse events" for each of the
serotonin, dopamine, and norepinephrine depression drugs are on this web page, as
you access information on each depression drug, notice near the top the warning
regarding, "Clinical worsening and suicide risk." The
serotonin, dopamine, and norepinephrine reuptake inhibitor drugs may deplete
serotonin, dopamine, or norepinephrine if levodopa, tyrosine, and
dopa are not administered simultaneously in proper balance. If you deplete the
serotonin, dopamine, and norepinephrine neurotransmitter levels enough
the clinical
depression picture worsens. The
worst case depression scenario is suicide due
to drug
depletion of the serotonin, dopamine, and norepinephrine neurotransmitter
levels.
Antidepressants
effectiveness
overview
|
